• About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • KLRG1
    • Abcuro Presentations & Publications
    • Other Publications
  • Programs
    • Overview
    • Ulviprubart
    • IBM
    • Clinical Trials
  • News
  • Careers
  • Contact
About About

About

Abcuro.com

Breakthrough Therapies for Autoimmune Diseases & Cancer

  • About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • KLRG1
    • Abcuro Presentations & Publications
    • Other Publications
  • Programs
    • Overview
    • Ulviprubart
    • IBM
    • Clinical Trials
  • News
  • Careers
  • Contact

Motschwiller, Ricky

October 4, 2026

Ricky Motschwiller is the Chief Financial Officer of Abcuro. Ricky joined Abcuro in 2021 and has held finance and accounting positions of increasing responsibility, most recently serving as Vice President of Finance. During his time at Abcuro, Ricky has led the company’s finance organization, overseeing financial planning and strategy, accounting and reporting, treasury, tax, and other corporate operations.

Prior to joining Abcuro, Ricky held finance and accounting leadership roles at Constellation Pharmaceuticals through its acquisition by MorphoSys. Previously, he was a consultant at Solas Consulting, advising public and private life sciences and technology companies on financial operations, financial reporting and technical accounting matters. Ricky began his career at PricewaterhouseCoopers in its assurance practice.

Ricky is a Certified Public Accountant and holds a BS in Accounting from Lehigh University.

Ricky Motschwiller

Chief Financial Officer

x

Ricky Motschwiller

Chief Financial Officer

Ricky Motschwiller is the Chief Financial Officer of Abcuro. Ricky joined Abcuro in 2021 and has held finance and accounting positions of increasing responsibility, most recently serving as Vice President of Finance. During his time at Abcuro, Ricky has led the company’s finance organization, overseeing financial planning and strategy, accounting and reporting, treasury, tax, and other corporate operations. Prior to joining Abcuro, Ricky held finance and accounting leadership roles at Constellation Pharmaceuticals through its acquisition by MorphoSys. Previously, he was a consultant at Solas Consulting, advising public and private life sciences and technology companies on financial operations, financial reporting and technical accounting matters. Ricky began his career at PricewaterhouseCoopers in its assurance practice. Ricky is a Certified Public Accountant and holds a BS in Accounting from Lehigh University.

Privacy Terms of Use

© 2026 Abcuro